0000899140-24-000250.txt : 20240214
0000899140-24-000250.hdr.sgml : 20240214
20240214163104
ACCESSION NUMBER: 0000899140-24-000250
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
EFFECTIVENESS DATE: 20240214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarissa Capital Management LP
CENTRAL INDEX KEY: 0001577524
ORGANIZATION NAME:
IRS NUMBER: 900924432
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15935
FILM NUMBER: 24639114
BUSINESS ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: 203-302-2330
MAIL ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001577524
XXXXXXXX
12-31-2023
12-31-2023
false
Sarissa Capital Management LP
660 STEAMBOAT ROAD
GREENWICH
CT
06830
13F HOLDINGS REPORT
028-15935
N
Alexander J. Denner, Ph.D.
Chief Investment Officer
203-302-2330
/s/ Alexander J. Denner
Greenwich
CT
01-30-2024
0
9
648896720
INFORMATION TABLE
2
informationtable.xml
AMARIN CORP PLC
SPONS ADR NEW
023111206
21620042
24850623
SH
SOLE
24850623
0
0
BIOCRYST PHARMACEUTICALS INC
COM
09058V103
5990000
1000000
SH
SOLE
1000000
0
0
BIOGEN INC
COM
09062X103
166389110
643000
SH
SOLE
643000
0
0
GILEAD SCIENCES INC
COM
375558103
87118154
1075400
SH
SOLE
1075400
0
0
INNOVIVA INC
COM
45781M101
116723080
7277000
SH
SOLE
7277000
0
0
IRONWOOD PHARMACEUTICALS INC
COM CL A
46333X108
187501600
16390000
SH
SOLE
16390000
0
0
NEUROCRINE BIOSCIENCES INC
COM
64125C109
61927200
470000
SH
SOLE
470000
0
0
REGULUS THERAPEUTICS INC
COM
75915K309
237034
185183
SH
SOLE
185183
0
0
VOR BIOPHARMA INC
COM
929033108
1390500
618000
SH
SOLE
618000
0
0